Trial
NCT00814333
Trial Comparing Outcomes With Merocel Packing or Thrombin-JMI for Anterior Epistaxis
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Kansas Medical Center
Collaborators
King Pharmaceuticals is now a wholly owned subsidiary of Pfizer
Condition
Epistaxis
Intervention
Thrombin-JMI
Why stopped
Product supplier change - bought out. Unable to enroll patients.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-01-15